Genmab — Oktober 2014
-
Revlimid det 10 dyreste lægemiddel pr. patient i verden: http://www.fiercepharma.com/special-reports/top-10-most-expensive-drugs-2013 Alexions lægemiddel klart dyrest
-
Dette interview William R. Strohl (VP hos Janssen) er ret interessant - http://www.bizjournals.com/philadelphia/blog/health-care/2014/08/why-the-next-big-biologic-may-be-found-by-montco.h
tml -
-
Strohl said one of the difficulties in developing bispecific antibodies is overcoming manufacturing hurdles. “Most can’t be manufactured,” he said. “I have to say we were a little frustrated that we couldn’t develop, internally, a technology that could be trusted to be manufacturable.”
Genmab’s technology proved to be the most promising solution. “We now have 20 bispecific licenses with them,” Strohl said.
-
Open Monoclonal Technology, Inc. (OMT), an innovator of novel genetic engineering of animals for creation of human therapeutic antibodies, today announced an alliance with Genmab A/S (OMX: GEN), a biotechnology company specializing in human antibody therapeutics. The deal gives Genmab unlimited access to OMT’s three OmniAb
platforms, OmniRat
, OmniMouse and OmniFlic -
-
Genmab vil have adgang til flere antistoffer som de kan kombinere i duobody
-
Det Europæiske Lægemiddelagentur har godkendt lægemidlet Imbruvica (ibrutinib) fra Janssen og partneren Pharmacyclics til to indikationer inden for behandling af blodkræft. Markedet skærpes nu for alvor for Genmab. Er der nogen der ønsker at kommentere på det ? I artiklen står der at Imbrutinib skulle være i fase 3 kombi med Arzerra .. har det sin rigtighed ?
-
Citat MedWatch i dag: ”Det store Genmab-håb er, at man succesfuldt kan kombinere Arzerra med Imbruvica. I øjeblikket er den kombinationsbehandling i fase 3, efter selvsamme kombination tidligere har vist særdeles stærke data i et mindre fase 2-studie”
-
Jeg kan ikke lide hvis anonyme skal til at sælge ud flere dage i træk
-
medwatch er gal på den. De har skrevet det 4-5 gange nu. kan være man burde gøre dem opmærksom på det
-
jeg kan ikke lide vi ikke har anonmyus med os mere. Afventer lige et par dage og ser om de fortsætter salget. men uden dem så vil en større korrektion give os et kæmpe slag ned
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind